홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Dimethylformamide → 1-{1-[4-(3-(N,N-di-tert-butoxycarbonylaminomethyl)phenyl)-piperidin-1-yl]-methanoyl}-3-methylsulfanyl-6,7-dihydro-5H-benzo[c]thiophen-4-one

HRID 2325159
인쇄

반응식

HRID 2325159 반응식
[B-:1]([F:2])([F:3])([F:4])[F:5].[C:47]([CH3:48])([CH3:49])([CH3:50])[O:51][C:52](=[O:53])[N:54]([C:55](=[O:56])[O:57][C:58]([CH3:59])([CH3:60])[CH3:61])[CH2:62][c:63]1[cH:64][c:65]([CH:69]2[CH2:70][CH2:71][NH:72][CH2:73][CH2:74]2)[cH:66][cH:67][cH:68]1.[CH3:23][S:24][c:25]1[c:26]2[c:27]([c:28]([C:30](=[O:31])[OH:32])[s:29]1)[CH2:33][CH2:34][CH2:35][C:36]2=[O:37].[CH3:75][N:76]([CH3:77])[CH:78]=[O:79].[CH:38]([N:39]([CH:40]([CH3:41])[CH3:42])[CH2:43][CH3:44])([CH3:45])[CH3:46].[n:6]1([O:7][C:8]([N:9]([CH3:10])[CH3:11])=[N+:12]([CH3:13])[CH3:14])[c:15]2[cH:16][cH:17][cH:18][cH:19][c:20]2[n:21][n:22]1>>[CH3:23][S:24][c:25]1[c:26]2[c:27]([c:28]([C:30](=[O:32])[N:72]3[CH2:71][CH2:70][CH:69]([c:65]4[cH:64][c:63]([CH2:62][N:54]([C:52]([O:51][C:47]([CH3:48])([CH3:49])[CH3:50])=[O:53])[C:55](=[O:56])[O:57][C:58]([CH3:59])([CH3:60])[CH3:61])[cH:68][cH:67][cH:66]4)[CH2:74][CH2:73]3)[s:29]1)[CH2:33][CH2:34][CH2:35][C:36]2=[O:37]
참가 물질출처 및 근거반응 노트

참가 물질

7

반응물 6

HCID 6228DimethylformamideHCID 26255TetrafluoroborateHCID 81531DiisopropylethylamineHCID 130500O-benzotriazol-1-yl-tetramethyluroniumHCID 6583903-methylsulfanyl-4-oxo-6,7-dihydro-5H-2-benzothiophene-1-carboxylic acidHCID 222661574-[3-(N,N-di-tert-butoxycarbonylaminomethyl)phenyl]piperidine

생성물

1
HCID 222660771-{1-[4-(3-(N,N-di-tert-butoxycarbonylaminomethyl)phenyl)-piperidin-1-yl]-methanoyl}-3-methylsulfanyl-6,7-dihydro-5H-benzo[c]thiophen-4-one

출처 및 근거

ORD 기록
ord-912e387d800e4a15b935fc882fe5c346
출처 데이터셋
Training data from https://doi.org/10.1039/C8SC04228D (10/10)
DOI
10.1039/C8SC04228D

반응 노트

이 페이지에서참가 물질출처 및 근거반응 노트